A detailed history of Onefund, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Onefund, LLC holds 4,637 shares of ABBV stock, worth $820,517. This represents 0.93% of its overall portfolio holdings.

Number of Shares
4,637
Previous 4,619 0.39%
Holding current value
$820,517
Previous $792 Million 15.58%
% of portfolio
0.93%
Previous 0.86%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $2,949 - $3,587
18 Added 0.39%
4,637 $916 Million
Q2 2024

Nov 13, 2024

BUY
$154.79 - $180.76 $6,346 - $7,411
41 Added 0.9%
4,619 $792 Million
Q1 2024

Nov 13, 2024

SELL
$159.82 - $182.1 $14,383 - $16,389
-90 Reduced 1.93%
4,578 $828 Million
Q4 2023

Nov 13, 2024

BUY
$137.6 - $154.97 $642,316 - $723,399
4,668 New
4,668 $723 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Onefund, LLC Portfolio

Follow Onefund, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Onefund, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Onefund, LLC with notifications on news.